bioMérieux
Clinical trials sponsored by bioMérieux, explained in plain language.
bioMérieux
BIM
EURONEXT PARIS
Biomérieux is a company in in vitro diagnostics, developing tests for infectious diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Quick test could transform ER care for kids with coughs and colds Results expected Sep 2026 (estimated)